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Abstract In the hours to days after intracerebral hemor-
rhage (ICH), there is an inflammatory response within the
brain characterized by the infiltration of peripheral neutro-
phils and macrophages and the activation of brain-resident
microglia and astrocytes. Despite the strong correlation of
aging and ICH incidence, and increasing information about
cellular responses, little is known about the temporal- and
age-related molecular responses of the brain after ICH.
Here, we monitored a panel of 27 genes at 6 h and 1, 3,
and 7 days after ICH was induced by injecting collagenase
into the striatum of young adult and aged rats. Several
molecules (CR3, TLR2, TLR4, IL-1β, TNFα, iNOS, IL-6)
were selected to reflect the classical activation of innate
immune cells (macrophages, microglia) and the potential
to exacerbate inflammation and damage brain cells. Most
of the others are associated with the resolution of innate
inflammation, alternative pathways of macrophage/micro-
glial activation, and the repair phase after acute injury
(TGFβ, IL-1ra, IL-1r2, IL-4, IL-13, IL-4Rα, IL-13Rα1,
IL-13Rα2, MRC1, ARG1, CD163, CCL22). In young
animals, the up-regulation of 26 in 27 genes (not IL-4)
was detected within the first week. Differences in timing
or levels between young and aged animals were detected for
18 of 27 genes examined (TLR2, GFAP, IL-1β, IL-1ra, IL-
1r2, iNOS, IL-6, TGFβ, MMP9, MMP12, IL-13, IL-4Rα,
IL-13Rα1, IL-13Rα2, MRC1, ARG1, CD163, CCL22),
with a generally less pronounced or delayed inflammatory
response in the aged animals. Importantly, within this com-
plex response to experimental ICH, the induction of pro-
inflammatory, potentially harmful mediators often coincided
with resolving and beneficial molecules.
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Introduction
Spontaneous intracerebral hemorrhage (ICH) is associated
with high mortality and morbidity: ~50% of patients die
within 6 months, and ~80% of survivors do not regain
functional independence [1, 2]. The greatest risk factor is
increasing age, and consequent increases in chronic hyper-
tension, amyloid angiopathy, and the use of anti-thrombotic
drugs, followed by hypertension [3–7]. Thus, ICH incidence
is expected to rise with the aging population demographic
and increasing hypertension rates in younger people [8]. In
young adults, hypertensive ICH results in smaller hematoma
volumes and better survival rates, but more severe disabil-
ities, suggesting age-related differences in the underlying
pathology [9]. Most experimental ICH studies use young
healthy animals, but age-related differences are emerging,
e.g., evidence that aged animals have altered glial scar
formation and microglial recruitment [10, 11], reduced
Electronic supplementary material The online version of this article
(doi:10.1007/s12975-012-0151-3) contains supplementary material,
which is available to authorized users.
S. Lively:L. C. Schlichter
Toronto Western Research Institute, University Health Network,
Toronto, ON, Canada
L. C. Schlichter
Department of Physiology, University of Toronto,
Toronto, ON, Canada
L. C. Schlichter (*)
Toronto Western Hospital, MC9-417,
399 Bathurst Street,
Toronto, ON, Canada M5T 2S8
e-mail: schlicht@uhnres.utoronto.ca
Transl. Stroke Res. (2012) 3 (Suppl 1):S132–S146
DOI 10.1007/s12975-012-0151-3lesion resolution [11], increased white matter damage [12],
more severe edema and autophagy [10, 13], and poorer
functional recovery [10, 13].
ICH is often described as having acute, secondary, and
resolution phases. In the acute injury phase (first few hours),
b l o o de x t r a v a s a t i o nf o r m sah e m a t o m a ,r e s u l t i n gi nt h e
physical destruction of adjacent tissue and mass effects that
compress surrounding structures [14]. The secondary phase,
which can last for days, includes hematoma expansion and
cerebral edema, resulting from blood–brain barrier (BBB)
breakdown in the tissue surrounding the clot [15, 16] and a
prominent inflammatory response with the infiltration of
neutrophils and monocytes, activation of resident microglia,
and cross talk with other brain cells. These events often
occur after hospital admission and are therefore temporally
amenable to therapeutic intervention [17–19]. Many studies
have focused on the initial capacity of the activated micro-
glia to promote bystander injury; however, the innate im-
mune response in the CNS, as in peripheral tissues, can
orchestrate the repair, reconstruction, and resolution of tis-
sue injury. There is a need for studies of the evolution of the
inflammatory response over time after ICH and comparisons
between young adult and aged animals.
We used real-time RT-PCR to compare the expression of
27 immune-related molecules in young and aged rats at 6 h
and 1, 3, and 7 days after ICH was induced by injecting
bacterial collagenase into the striatum, a model we have
previously used to study inflammation and damage to gray
and white matter [11, 12, 20–23]. Our salient earlier findings
(illustrated in the summary image in Electronic Supplemen-
tary Material (ESM) Fig. S1) are as follows. Neutrophils
infiltrate the hematoma only and at early times (1 and 3 days)
and then die off. By day 3, there is extensive neuron death,
damage to myelin and axons, and infiltration of the damaged
axon bundles by activated microglia and macrophages with-
in and at the edge of the hematoma. Over the first several
days, the hematoma becomes filled with activated microglia
and macrophages, and a glial scar forms at the lesion edge,
with a band of activated microglia and macrophages sur-
rounded by reactive astrocytes. Therefore, we selected this
time course to analyze the expression of inflammation-
related genes, including pro- and anti-inflammatory media-
tors, tissue remodeling enzymes, and markers of different
states of macrophage/microglia activation.
Materials and Methods
Induction of Intracerebral Hemorrhage
All procedures were performed on male Sprague–Dawley
rats in accordance with the guidelines established by the
Canadian Council on Animal Care and approved by the
Animal Care Committee at the University Health Network.
Young adult rats (n036) were 3–4 months old and 350–
500 g at the time of surgery (Charles River, St-Constant,
Canada). Aged rats (n035) were purchased at 10–11 months
old from Harlan Laboratories (Mississauga, Canada) and
maintained in our animal facility until 20–21 months old
and 450–600 g. With a mean life span of ~25 months for this
rat strain [24], this corresponds to early old age in humans.
ICH was induced in the anterior striatum (caudate + puta-
men), as we recently described [12, 20]. In brief, rats were
anesthetized with isoflurane (3.5% induction, 1.5% mainte-
nance), placed in a small-animal stereotaxic instrument (Da-
vid Kopf Instruments, Tujunga, CA), and a 1-mm diameter
burr hole was drilled 0.2 mm anterior and 3.5 mm lateral to
bregma. A 30-gauge needle attached to a micropump (Ultra-
MicroPump II, World Precision Instruments, Sarasota, FL)
was lowered 6 mm ventral to the skull surface into the right
caudate putamen.
ICH was evoked by injecting bacterial type IV collage-
nase (Sigma-Aldrich, Oakville, Canada) to rupture blood
vessels. This is a well-characterized model [25–28] that we
have used extensively [11, 12, 20–23] (and see ESM Fig.
S1). Collagenase was diluted in sterile physiological saline,
and the injected amounts (0.2 U for young adult rats, 0.15 U
for aged rats; both in 0.5 μL saline) were chosen to produce
lesions that were limited to the striatum (examples shown in
Fig. 1a). Using the lower dose in aged rats minimized
mortality and created lesion sizes that were comparable to
those in young adult rats [11]. Note that lesion size cannot
be measured in the same animals used for real-time RT-PCR
because the whole striatum is rapidly harvested to preserve
the mRNA. However, visual inspection of the hematoma
before harvest did not identify apparent differences in size
between young and aged animals. Control animals were
time- and age-matched sham-operated rats that received
intrastriatal injections of 0.5 μL saline. In all cases, the
injection rate was 0.25 μL/min, after which the needle was
left in place for 5 min to prevent solution reflux. Core body
temperature was maintained at 36.5°C throughout the sur-
gery and recovery period using a thermostat-regulated heat-
ing pad. All rats survived and regained consciousness within
10 min. As expected, all rats with an ICH (but not saline-
injected control rats) demonstrated an ipsilateral turning
bias, while their grooming and feeding behavior appeared
normal.
Tissue Preparation
Cohorts of animals were killed by an overdose of isoflurane
at 6 h and 1, 3, or 7 days after surgery. For real-time RT-
PCR, animals were perfused transcardially with 120 mL of
cold PBS (0.1 mol/L phosphate-buffered saline, pH 7.5).
Brains were removed, placed in a rat brain matrix (Ted Pella
Transl. Stroke Res. (2012) 3 (Suppl 1):S132–S146 S133Inc., Redding, CA), submerged in ice-cold PBS, and cut
2 mm anterior and 2 mm posterior to the needle entry site,
which was easily identified on the brain surface. Each 4-
mm-thick coronal section was divided along the midline
into an ipsilateral (hematoma-bearing) and contralateral
hemisphere, and the striatum was isolated from each slice
and snap-frozen on dry ice. Tissue was stored at −80°C until
used for RNA extraction. For immunohistochemistry, ani-
mals were perfused transcardially with PBS (as above),
followed by fixative (120 mL cold PBS-buffered 4%
paraformaldehyde; EMD Biosciences, Gibbstown, NJ).
Brains were removed and processed at 4°C: first in fixative
(24 h), then in 10% sucrose in PBS (24 h), and finally in
30% sucrose in PBS until the brains sank. The cryoprotected
brains were placed in a brain matrix; coronal slices were
made at 3, 6, and 9 mm from the anterior and then mounted
in Tissue Freezing Medium (Somagen Diagnostics, Edmon-
ton, Canada) and stored at −40°C. Frozen brain sections
(16 μm thick) were made on a cryostat (model CM350S,
Leica, Richmond Hill, Canada), collected on gelatin-coated
Fig. 1 The collagenase model of ICH and the use of the contralateral
striatum for animal- and age-matched comparisons. a A representative
young adult rat showing that stereotaxic injection of type IV collage-
nase produced a hematoma that was restricted to the ipsilateral stria-
tum. Much of the blood clot has been resorbed by day 7. b In a saline-
injected control rat, the needle penetration track is seen (arrowhead)
without bleeding in the striatum. c Representative confocal images of
the contralateral striatum at 1, 3, and 7 days after ICH show normal
white matter bundles labeled with myelin basic protein (MBP, green)
and lack of degraded MBP (red). d In the contralateral striatum at 1, 3,
and 7 days after ICH, microglia, identified with Iba1 (red)a r eo f
ramified morphology and broadly distributed between the white matter
tracts. Scale bars, 500 μm
S134 Transl. Stroke Res. (2012) 3 (Suppl 1):S132–S146slides (1% gelatin, 0.5% chromium potassium sulfate), and
stored at −40°C until used.
Quantitative Real-Time Reverse Transcriptase Polymerase
Chain Reaction
Gene-specific primers (Table 1) were designed using “Pri-
mer3Output” (http://frodo.wi.mit.edu/cgi-bin/primer3/
primer3_www.cgi). Total RNAwas extracted using the TRI-
zol method (Invitrogen), followed by further purification
using the RNeasy Mini Kit (Qiagen, Mississauga, ON),
and a two-step reaction was performed according to the
manufacturer’s instructions (Invitrogen). In brief, total
RNA (0.8 μg) was reverse-transcribed in 20 μL volume
using 200 U of SuperScriptII RNase reverse transcriptase,
with 0.5 mM dNTPs and 0.5 μM oligo dT (Invitrogen).
Amplification was performed on an ABI PRISM 7900 Se-
quence Detection System (PE Biosystems, Foster City, CA)
at 95°C for 10 min, 40 cycles at 95°C for 15 s, and 56°C for
20 s. “No-template” and “no-amplification” controls were
included for each gene, and melt curves showed a single
peak, confirming specific amplification. The threshold cycle
(CT) for each gene was normalized to that of the housekeep-
ing gene, hypoxanthine guanine phosphoribosyl transferase
(HPRT1), which we have found to be especially stable in the
brain. Results in Figs. 2, 3, 4, 5, 6,a n d7 are mRNA
expression relative to the level in control rats injected with
saline (mean ± SEM, n04–6 rats per age group per time
point). For statistical analysis, two-way ANOVA and Bon-
ferroni post hoc tests were conducted using GraphPad Prism
ver 5.01 (GraphPad Software, San Diego, CA).
Immunohistochemistry
Frozen brain sections mounted on slides were thawed at
room temperature and rehydrated for 20 min in PBT buffer
(0.1 mol/L PBS, pH 7.5, 0.1% bovine serum albumin, 0.2%
Triton X-100). To reduce nonspecific antibody binding,
slides were blocked for 2 h in 10% donkey serum in PBT.
Brain sections were then incubated overnight at room tem-
perature in PBT buffer that contained one or two of the
following primary antibodies. Axon bundles were labeled
with a mouse monoclonal antibody against myelin basic
protein (MBP; 1:100; Sigma-Aldrich), and regions of mye-
lin damage or demyelination were identified with a rabbit
polyclonal antibody that recognizes only degraded MBP
(dMBP, 1:250; Chemicon, Temecula, CA). The microglia
were labeled with rabbit polyclonal anti-ionized calcium-
binding adapter-1 (Iba1; 1:1,000; Wako, Japan) or a mouse
monoclonal anti-ED1 antibody (1:100; Serotec, Raleigh,
NC) which labels CD68 in the lysosomes of activated
phagocytic microglia/macrophages. Microvessels were la-
beled with a rabbit polyclonal antibody against collagen
Table 1 Primers used for real-time RT-PCR
Gene GenBank
accession no.
Primer sequences
ARG1 NM_017134.1 FP: GTCTGTGGGAAAAGCCAATG
RP: TTGCCATACTGTGGTCTCCA
CR3 NM_012711 FP: TGCTGAGACTGGAGGCAAC
RP: CTCCCCAGCATCCTTGTTT
CCL22 NM_057203.1 FP: AGGATGCTCTGGGTGAAGAA
RP: TAGGGTTTGCTGAGCCTTGT
CD163 NM_001107887.1 FP: ATCACAGCATGGCACAGGT
RP: TCCAGATCATCCGTCTTCG
CHI3L1 NM_053560 FP: GGGCAGTGGATTTGGATG
RP: TGCAAGTGACCAGACTCCTG
GFAP NM_017009.1 FP: CAGCTTCGAGCCAAGGAG
RP: TGTCCCTCTCCACCTCCA
ICE NM_012762 FP: CCAACCACTGAAAGGGTGA
RP: GCATGATTCCCAACACAGG
IL-1β NM_031512 FP: TGACCCATGTGAGCTGAAAG
RP: AGGGATTTTGTCGTTGCTTG
IL-1ra/IL-1rn NM_022194 FP: GGGAAAAGACCCTGCAAGA
RP: GTGGATGCCCAAGAACACA
IL-1r2 NM_053953.1 FP: GTGATCATTTCTCCCCTGGA
RP: CACGATGGTGTTGGAAGATG
IL-6 NM_012589 FP: CAGGAACGAAAGTCAACTCCA
RP: ATCAGTCCCAAGAAGGCAACT
IL-4 NM_201270.1 FP: CAAGGAACACCACGGAGAA
RP: TTCAGACCGCTGACACCTC
IL-4rα NM_133380.2 FP: TCCGCACTTCTACGTGTGAG
RP: AGACCACAGTTCCAGCCAGT
IL-13 NM_053828.1 FP: TCTGTGCAGCCCTGGAAT
RP: GCGGAAAAGTTGCTTGGA
IL-13rα1 NM_145789.2 FP: AGAAACATGGAGGGTGCAAG
RP: CACTGCGACAAAGACTGGAA
IL-13rα2 NM_145789.2 FP: AGAAACATGGAGGGTGCAAG
RP: CACTGCGACAAAGACTGGAA
iNOS NM_012611 FP: GCTACGCCTTCAACACCAA
RP: GCTTGTAACCACCAGCAGT
MRC1 NM_001106123 FP: AAGGTTCCGGTTTGTGGAG
RP: TGCATTGCCCAGTAAGGAG
MMP-3 NM_133523 FP: TCCCACAGAATCCCCTGA
RP: CGCCAAAAGTGCCTGTCT
MMP-9 NM_031055 FP: CTGCCTGCACCACTAAAGG
RP: GAAGACGAAGGGGAAGACG
MMP-12 NM_053963 FP: CTGGGCAACTGGACACCT
RP: CTACATCCGCACGCTTCA
TIMP1 NM_053819 FP: GGTTCCCCAGAAATCATCG
RP: GGAAACCTGTGGCATTTCC
TACE NM_020306 FP: TGTGAGCAGTTTCTCGAACG
RP: AAAGGCACCAAAGTGGTCAG
TGFβ1 NM_021578.1 FP: ATACGCCTGAGTGGCTGTC
RP: GCCCTGTATTCCGTCTCCT
TLR2 NM_198769.2 FP: CTGCAAGCTCTTTGGCTCTT
RP: ACACACCAGCAGCATCACAT
TLR4 NM_019178.1 FP: TGCTCAGACATGGCAGTTTC
RP: GCGATACAATTCGACCTGCT
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constituent of the basal lamina in cerebral blood vessels
[29]. After labeling with primary antibodies, brain sections
were washed in PBS (3×10 min) and incubated for 2 h at
room temperature in the dark with appropriate secondary
antibodies diluted to 1:400 in PBT, i.e., DyLightTM488-
conjugated AffiniPure donkey anti-mouse IgG,
DyLightTM594-conjugated AffiniPure donkey anti-rabbit
or anti-mouse (Jackson Immunoresearch, Mississauga, Can-
ada). To stain cell nuclei, 4′-6-diamidino-2-phenylindole
(DAPI; 1:5,000; Sigma-Aldrich) was applied for 5 min.
After washing in PBT (3×20 min), slides were coverslipped
using Vectashield mounting medium (Cedarlane, Burling-
ton, Canada) and stored in the dark at 4°C. All images
shown are representative examples of at least three animals
at each indicated time point.
Results
Because ICH commonly occurs in deep nuclei of the cere-
brum, pons, cerebellum, and in deep white matter [2], we
have been studying the anterior striatum of the rat (caudate
and putamen) [11, 12, 20–23]. After collagenase is injected
into the striatum, a hematoma rapidly develops and then the
blood clot is gradually resorbed over several days (Fig. 1a),
leaving a lesion with neuron death, white matter damage,
BBB disruption, and extensive accumulation of the activat-
ed microglia/macrophages (the collective term reflects that
the cells become morphologically indistinguishable after
microglia processes retract). ESM Fig. S1 shows examples
of immunostaining to illustrate the temporal–spatial evolu-
tion of the ICH lesion. In saline-injected control rats
(Fig. 1b) ,t h en e e d l et r a c kc a nb es e e n ,b u tt h e r ei sn o
bleeding in the striatum. The contralateral striatum was
uninjured (Fig. 1c, d); it showed normal MBP staining of
white matter tracts (bundles of penetrating axons in cross-
section), no dMBP, and normal microglia with a “resting”
ramified morphology. Therefore, over the 7-day time course
of the present study, we routinely compared the damaged
ipsilateral striatum with saline-injected control animals and
used the contralateral striatum as an animal- and time-
matched internal reference [20, 23]. Importantly, the colla-
genase dose was titrated to obtain comparable sized lesions
in young and aged rats (examples in Fig. 2a)[ 11].
Time-Dependent Glial Cell Activation in Young and Aged
Rats
The inflammatory response after ICH is characterized by
neutrophil and monocyte infiltration, activation of endog-
enous microglia and astrocytes, and production of numer-
ous inflammatory mediators, including cytokines and
matrix metalloproteases (MMPs). We previously quanti-
fied the time-dependent accumulation of activated micro-
glia/macrophages over the first week in this ICH model
[12, 20, 22]( a n ds e eE S MF i g .S 1). In young rats, most of
the blood clot was resorbed by 7 days (Fig. 1a), presum-
ably due to phagocytosis. Interestingly, activated micro-
glia/macrophages in the lesion were not homogeneous
(Fig. 2a); Iba1-labeled cells filled the lesion, while those
labeled with the lysosomal marker, ED1 (an indicator of
phagocytic capacity) were more concentrated at the pe-
riphery, where we previously showed a zone of dramatic
neuron loss [11, 22] (and see ESM Fig. S1). Despite
ensuring initially similar-sized hematomas in young adult
and aged rats, by 7 days the lesion of aged rats showed
less Iba1 labeling and fewer total cell numbers (nuclei
stained with DAPI). ED1 staining was more diffuse and
extended further into the surrounding striatum. Based on
these results and previously reported differences between
young and aged rats (see “Discussion”), we examined the
time course (6 h, 1, 3, and 7 days) of induction of 27
genes associated with inflammation.
We assessed gene transcript expression in each ipsilateral
and contralateral striatum (four to six rats per group). In
order to identify ICH-induced changes, values on the Y-axes
(Figs. 2, 3, 4, 5, 6, and 7) indicate fold changes normalized
to age- and time-matched, saline-injected control animals
(set to 1.0, dashed line in each panel). Because increased
basal levels of cytokines (TNFα,I L - 1 α,I L - 1 β,I L - 6 ,
TGFβ) have been reported in the aging naive rodent brain
[30–32], we have not compared basal levels in young and
aged control animals.
First, we monitored several molecules that are commonly
used to assess gliosis and inflammation after acute brain
injury [33–35], i.e., the astrocyte marker, glial fibrillary
acidic protein (GFAP), and the microglia/macrophage
markers, complement receptor 3 (CR3/CD11b) and
Toll-like receptors, TLR2 and TLR4. Over the first week
after ICH, GFAP and CR3 increased in the damaged ipsi-
lateral striatum of young rats (Fig. 2b) and reached levels
several-fold higher than saline-injected controls. The main
difference in aged rats was the lack of up-regulation of
GFAP at 1 day, which might reflect slower development of
Table 1 (continued)
Gene GenBank
accession no.
Primer sequences
TNF-α NM_012675 FP: GCCCACGTCGTAGCAAAC
RP: GCAGCCTTGTCCCTTGAA
HPRT-1 NM_012583.2 FP: CAGTACAGCCCCAAAATGGT
RP: CAAGGGCATATCCAACAACA
FP forward primer, RP reverse primer
S136 Transl. Stroke Res. (2012) 3 (Suppl 1):S132–S146(Caption on next page)
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matter injury extends further in aged rats [12]. While CR3
was suggestive of a lower expression in aged animals, more
data would be needed. The up-regulation of TLR2 and
TLR4 expression further indicates an innate immune re-
sponse, but interestingly, in young animals, TLR2 clearly
preceded TLR4 induction (6 h vs. 7 days). Activation of
microglia is thought to depend on the TLR2/TLR4
activation sequence, with TLR2 activation decreasing
TLR4 transcription and downstream expression of several
Fig. 3 Temporal expression of IL-1β and its regulatory molecules in
young adult and aged rats after ICH. Transcript expression was mea-
sured, analyzed, and expressed as in Fig. 2b for interleukin-1β (IL-1β),
interleukin-1-converting enzyme (ICE), the endogenous IL-1 receptor
antagonist (IL-1ra), and type 2 IL-1 receptor (IL-1r2)
Fig. 4 Temporal expression of hallmark inflammatory molecules after
ICH in young adult and aged rats. Transcript expression was measured,
analyzed, and expressed as in Fig. 2b for inducible nitric oxide syn-
thase (iNOS/NOS2), tumor necrosis factor-α (TNFα), TNFα-
converting enzyme (TACE), interleukin-6 (IL-6), and transforming
growth factor-β (TGFβ)
Fig. 2 Time-dependent glial cell accumulation and activation. a Low
magnification coronal images of the hematoma at 7 days post-ICH in
representative young adult and aged rats. Microglia and macrophages
were labeled with Iba1 (red) and the lysosomal marker, ED1 (green).
Adjacent serial sections were stained with the nuclear dye, DAPI
(blue). Scale bars, 500 μm. b Expression of several markers of glial
responses after ICH: astrocyte marker, glial fibrillary acidic protein
(GFAP); microglia/macrophage markers, complement receptor 3
(CR3), Toll-like receptors, TLR2 and TLR4. After two-way ANOVA
with Bonferroni correction, the following significant intergroup differ-
ences are indicated:
#In ipsilateral vs. contralateral striatum; *With
time;
†Between young adult and aged rats. One symbol of any type
signifies p<0.05; two symbols, p<0.01; three symbols, p<0.001
R
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In aged animals, TLR2 and TLR4 showed a delay and a
similar time course, with the highest expression on days 3
and 7 (none of the four genes was up-regulated in the
contralateral striatum).
Time- and Age-Dependent Induction of Pro-inflammatory
Genes and MMPs
The pro-inflammatory cytokine, IL-1β, is one of the earliest
mediators induced and is considered a principal orchestrator
of inflammation after acute CNS injury [37]. IL-1β function
requires interleukin-1 converting enzyme (ICE/caspase 1)
which cleaves pro-IL-1β to its mature, active form [38, 39].
The bioavailability of IL-1 is reduced by specific decoy
receptors expressed on the macrophage/microglia surface
or secreted into the local environment, i.e., the IL-1 receptor
antagonist (IL-1ra), which binds to the receptors without
inducing a cellular response [40], and the type 2 IL-1 recep-
tor (IL-1r2), which acts as a decoy receptor [41]. In young
animals, there was a marked and rapid IL-1β induction after
ICH (~25-fold increase over controls by 6 h), after which
the expression progressively declined (Fig. 3). ICE up-
regulation was lower (at most ~4-fold) and lagged behind,
Fig. 5 Temporal expression of matrix metalloprotease-related genes
after IHC in young adult and aged rats. Transcript expression was
measured, analyzed, and expressed as in Fig. 2b for the matrix metal-
loproteases, MMP3, MMP9, MMP12, and the endogenous tissue in-
hibitor of metalloproteinases (TIMP1)
Fig. 6 Temporal expression in young adult and aged rats of genes
involved in alternative macrophage/microglia activation. Transcript
expression was measured, analyzed, and expressed as in Fig. 2b for
interleukin-4 (IL-4), interleukin-13 (IL-13), and their receptors, IL-
4Rα, IL-13Rα1, IL-13Rα2
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lower (~10-fold increase at 6 h), and ICE induction was
delayed until day 3. Striking age-related differences were
seen for the endogenous antagonists, IL-1ra and IL-1r2.
Both showed a dramatic and early induction in young rats;
for instance, at 6 h, the increases were ~27-fold for IL-1ra
and ~15-fold for IL-1r2. In aged rats, neither antagonist was
significantly elevated until 3 days, which suggests that func-
tionally active IL-1β might be elevated in the aged (NB: In
the contralateral striatum, there was no induction of ICE, IL-
1ra or IL-1r2, while IL-1β was increased slightly at 6 h in
young animals).
Inducible nitric oxide synthase (iNOS/NOS2) produces
nitric oxide which can contribute to the neurotoxic capacity
of activated microglia and macrophages [42–45]. A striking
age-related difference in iNOS induction was seen (Fig. 4).
In young adult rats, iNOS expression increased rapidly and
dramatically after ICH (~60-fold at 6 h) and then declined
over the next 3 days. In contrast, induction in the aged
(ipsilateral vs. contralateral) was not statistically significant
at any time examined. Tumor necrosis factor-α (TNFα)i s
an early orchestrator of the inflammatory response after
acute brain injury [46] and is activated by the TNFα-
converting enzyme, TACE/ADAM17 [47]. In young rats,
TNFα induction followed a similar trend to IL-1β: rapid up-
regulation (6 h and 1 day) and a time-dependent decline. In
aged animals, TNFα was increased only at 6 h. Interesting-
ly, TACE was only increased at 3 days and reached a higher
level in aged animals. Interleukin-6 (IL-6) is a pleiotropic
cytokine, and its expression is regulated by the classical IL-
1 pathway [48]. In young rats, IL-6 was markedly elevated
early after ICH (15- to 20-fold higher than controls at 6 h
and 1 days) and then declined to baseline by 3 days. In aged
rats, IL-6 induction showed a gradual increase and peaked at
3 days. Transforming growth factor-β (TGFβ) is thought to
promote the damage resolution phase after acute CNS inju-
ries [49], including glial scar formation [50]. In young rats,
TGFβ increased transiently at 3 days, but elevation was
more prolonged in aged rats (3 and 7 days).
MMPs contribute to extracellular matrix remodeling and
cleavage of precursor molecules, but their elevation after
ICH also correlates with blood BBB disruption, hematoma
expansion, and edema (reviewed in [51]). There were
marked increases in MMP12 in both age groups (150- to
200-fold over control rats), which peaked at 3 days in the
young but continued to increase at 7 days in the aged animals
(Fig. 5). In contrast, there was little change in MMP3 and
MMP9 in the young rats (at most a 2- to 2.5-fold increase
over control rats), and they were not up-regulated in aged
rats. After a slight increase in MMP3 at 6 h in the young
animals, an apparent oscillation with time (lower at 1 and
7 days) did not significantly differ from controls. The small
changes in MMP9 were difficult to interpret because the
levels apparently increased and oscillated in the contralateral
striatum. The endogenous tissue inhibitor of matrix metal-
loproteases (TIMP1), which regulates the activity of all three
MMPs, was elevated on days 1, 3, and 7 in the young, but
only on day 3 in aged rats.
Fig. 7 Temporal expression of markers of alternative activation in
young adult and aged rats. Transcript expression was measured, ana-
lyzed, and expressed as in Fig. 2b for mannose receptor-1 (MRC1),
arginase 1 (ARG1), the haptoglobin–hemoglobin scavenger receptor
(CD163), chemokine (C–C motif) ligand 22 (CCL22), and chitinase 3-
like 1 (CHI3L1)
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and Alternative Activation Genes
The initial pro-inflammatory phase after acute injury is
characterized by classical (also called M1) activation of
macrophages and microglia. This is followed by resolution
of the defense response and a repair phase, with changes in
the state of macrophages/microglia to what is variously
called M2, alternative activation, or acquired deactivation,
states that are most readily defined by stimuli and outcomes
invitro(reviewedin[52,53]).Whilerecognizingthatmultiple
stimuli are present after acute damage in vivo, for simplicity,
we will use the term alternative activation when describing
resolving and repairgenes.Theobservedspatialdifferencesin
Iba1 and ED1 expression in activated microglia/macrophages
(Fig. 2a), and differing temporal expression of TLR2 and
TLR4 between young and aged rats (Fig. 2b), point to a
complexity in their activation states after ICH. We first ana-
lyzed changes in the expression of two known inducers of
alternative macrophage/microglia activation (IL-4 and IL-13)
and the three receptors through which they act: IL-4Rα,I L -
13Rα, and IL-13Rα2( F i g .6). IL-13, IL-4Rα, and IL-13Rα1
increased above control levels, and this occurred later in aged
rats, i.e., IL-4Rα at 1 and 3 days in young vs. 3 and 7 days in
aged;IL-13Rα1at1,3,and7 daysinyoungvs.3daysonlyin
aged; IL-13 at 6 h in young vs. 1 and 3 days in aged rats. IL-4
was not significantly increased above control levels and in-
stead was apparently suppressed early after ICH in aged rats
(6 h). IL-13Rα2 only increased above control levels in the
young and only at 7 days.
Next, we monitored the expression of several well-
known markers of alternatively activated macrophages/
microglia: mannose receptor (MRC1/CD206), arginase 1
(ARG1), haptoglobin–hemoglobin scavenger receptor
(CD163), and chemokine (C-C motif) ligand 22 (CCL22).
In young adult rats, all four markers rapidly increased: by
6 h for CCL22 and by 1 day for the others. MRC1 and
CD163 increased further with time, and while MRC1 was
sustained until 7 days, the other genes decreased. There
were several notable differences in the aged rats: MRC1
was induced later, but was higher at 7 days; ARG1 was
lower at 1 day; CD163 was lower at 1 and 3 days, but
higher at 7 days; and CCL22 was lower at 6 h and 1 day.
Together, these results suggest that alternative activation
was delayed in the aged animals. Because ARG1 metabo-
lizes L-arginine to produce L-ornithine, which can be further
metabolized into L-proline, a substrate for collagen synthesis
[54], we examined the basal lamina component, collagen
type IV (CgIV; Fig. 8). At 1 and 3 days after ICH, CgIV
localized to blood microvessels, including fragmented ves-
sels inside the hematoma. At 1 day, some white matter
bundles inside the hematoma still stain for myelin basic
protein, but they are swollen and disrupted, as we have
previously shown [20]. Surprisingly, at 7 days, in addition
to pronounced microvessel staining around the lesion, the
core was filled with a more diffuse deposit of CgIV that
appeared as a fibrotic clot. This response in the core was
evident at 7 days in both young and aged animals, and there
was no apparent difference in the time course of cgIV
accumulation. Not all genes associated with alternative ac-
tivation differed with age, e.g., chitinase 3-like 1 (CHI3L1),
which can also induce alternative macrophage activation
[55], was up-regulated at 1 and 3 days in both age groups.
Discussion
Despite the evidence that inflammation plays a crucial role
in ICH pathology, surprisingly little is known about the
timing of molecular changes, especially in aged rats. A
microarray study on humans [56] and two on young adult
rats [57, 58] examined a single time point (24 h) and noted
changes in many immune-related molecules, including IL-
1β, IL-1 receptor type 2, IL-6 receptor, TGFβ, TLR1, TNF
receptor, IL-13Rα1, IL-10 receptor β, interferon receptor 2,
macrophage inflammatory protein-2 precursor, prepro- com-
plement C3, and MHC class II RT1-B region Ia antigen.
Temporal changes in young rodents are beginning to
be examined, but have been limited to a few pro-
inflammatory (C3, CR2, IL-1β, IL-6, interferon-γ, NF-κB,
TNFα) and inflammation-resolving molecules (IL-10,
TGFβ)[ 59, 60]. We previously analyzed several inflamma-
tory genes (CR3, ICE, TACE, IL-1ra) and MMPs (MMP3,
MMP9, MMP12) following ICH in young rats [21, 23], and
the recent study on mice [59] is in good agreement with our
results. The present study is unique in that it analyzes: (1)
27 genes selected to encompass a broad spectrum of
inflammation-related molecules, including pro- and anti-
inflammatory mediators, tissue remodeling enzymes, and
markers of different states of macrophage/microglia activa-
tion; (2) four time points (6 h and 1, 3, and 7 days) that
bracket the secondary injury phase; (3) the ipsilateral and
contralateral striatum, after normalizing to time-matched
saline-injected control rats; and (4) young adult and aged
rats at each time point.
Several cell types have the potential to produce inflam-
matory mediators after brain injury, including endogenous
microglia and astrocytes, and infiltrating neutrophils and
macrophages [61, 62]. Before discussing changes in gene
expression, it is worth considering cellular responses, which
have been mainly studied in young animals (reviewed in
[63, 64]). Neutrophils begin to infiltrate as early as 4 h [65]
and are an important source of TNFα and IL-1β [66], which
help recruit blood monocytes/macrophages [67]. Early
microglial activation can occur in the peri-hematomal region
[63, 68, 69]. In the ICH model used in this study (see ESM
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type IV (CgIV) staining after
ICH. Representative confocal
images of young (a) and aged
(b) rats show myelin basic
protein (MBP, green) labeling
of white matter tracts and CgIV
staining (red). The hematoma
(H) is readily seen as loss of
MBP staining. At 1 and 3 days,
CgIV localized to blood
microvessels. At 7 days, the
staining intensity greatly
increased inside the lesion.
Scale bars, 100 μm
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response with rapid infiltration of neutrophils (within hours)
and later activation of microglia and astrocytes, infiltration
of blood monocytes/macrophages, and white matter dam-
age. By 3 days after ICH induction, activated microglia,
macrophages, and astrocytes formed a glial scar surrounding
the hematoma. Neutrophil depletion reduced the activation
of microglia, macrophages, and astrocytes and decreased
BBB breakdown and axon damage [20]. Here, as early as
6 h after ICH in young adult rats, we observed increases in
the expression of TLR2, IL-1β, IL-1ra, IL-1r2, iNOS,
TNFα, IL-6, MMP3, IL-13, IL-4Rα, and CCL22. These
increases are too early for macrophage infiltration [70] and
might be due to neutrophil infiltration (e.g., TNFα was
mainly in neutrophils early after ICH [20, 21]) or the
responses of endogenous brain cells, including microglia,
to blood products. Of note is that thrombin is produced in
the brain immediately after ICH, and it can induce microglia
to secrete pro-inflammatory molecules (IL-1β, TNFα)[ 71]
and chemotactic factors that recruit blood leukocytes [72].
There are reports of poorer functional recovery after ICH
in aged animals [10, 13, 73] and histological differences,
including reduced lesion resolution [11], more white matter
damage [12], more severe edema and autophagy [10, 13],
and decreased synaptogenesis and angiogenesis [74]. All of
these factors likely contribute to poorer functional out-
comes, but how might the inflammatory response contrib-
ute? Reduced neutrophil infiltration has been reported in
aged rats after ICH [75], and we observed a more wide-
spread distribution of ED1-labeled phagocytic microglia/
macrophages [11] (present study), especially in damaged
white matter bundles [20]. Here, we found differences be-
tween young adult and aged rats in induced levels and/or
timing for 18 of the 27 genes examined: TLR2, GFAP, IL-
1β, IL-1ra, IL-1r2, iNOS, IL-6, TGFβ, MMP9, MMP12,
IL-13, IL-4Rα,I L - 1 3 R α1, IL-13Rα2, MRC1, ARG1,
CD163, CCL22. Most were delayed induction or lower
levels in aged rats, with several differing as early as 6 h
(TLR2, IL-1β,I L - 1 r a ,I L - 1 r 2 ,i N O S ,C C L 2 2 ) ,a n dt h u s
likely reflecting changes in neutrophil infiltration and damp-
ened responses of endogenous brain cells. Given the many
changes observed, rather than discussing every gene, we
will focus on functional groupings, as in “Results.“
As markers of the glial response, the induction of GFAP
and TLR2 was delayed in aged rats, CR3/CD11b up-
regulation was reduced, and, at 7 days, ED1-labeled activated
microglia/macrophages were more diffusely distributed in the
surroundingstriatum.IL-1βisaprincipalorchestratorofbrain
inflammation [37] which contributes to activating microglia
[48], astrocytes [76–78], and endothelial cells [62]t h a tt h e n
secrete IL-1β and other inflammatory molecules. IL-1β has
been the focus of many experimental studies of ischemic
stroke [79]. Intracerebroventricular or stereotaxic striatal
injection of exogenous IL-1β exacerbated stroke-induced
damage in young animals [80], and conversely, injury was
reduced after the IL-1β antagonist, IL-1ra, was injected either
locally into the striatum [81] or into an intracerebral ventricle
[82]. Here, we found that early after ICH, young rats had a
higher expression of IL-1β and its regulatory molecules, IL-
1ra and IL-1r2, possibly as a compensatory response, as well
as higher iNOS and IL-6 levels. In aged rats, the increase in
IL-6 was delayed and TGFβ elevation was prolonged. Our
results demonstrate the complexity and differences between
young adult and aged rats in mediators generally associated
with classical (or M1) macrophage/microglia activation.
In order to restore tissue homeostasis, it is expected that
macrophage/microglia activation will shift from a pro-
inflammatory gene profile to one that supports repair and
tissue reconstruction. In peripheral tissue, this switch is
induced primarily by the anti-inflammatory cytokines, IL-
4, IL-13, IL-10, and TGFβ (reviewed in [52, 53, 83, 84]).
Interestingly, IL-4 knockout mice had a larger infarct vol-
ume and poorer neurological outcome after ischemic stroke
[85]. In this first study of alternative activation markers after
ICH or in aged animals, we observed the induction of IL-13
(by 1 day) and TGFβ (by 3 days) and a delay in aged rats.
We previously showed IL-10 induction at 6 h and 7 days in
young rats [23]. IL-4 was expressed in the striatum of
control rats, but not increased after ICH. IL-4 and IL-13
bind to IL-4Rα and IL-13Rα1 chains in the type II receptor
[83], and while it has been reported that IL-4 and IL-13
mRNA and protein levels in the brain are highly variable
[86], IL-4 receptors are found on microglia and astrocytes
[87]. IL-4Rα and IL-13Rα1 were up-regulated after ICH,
but after a delay in the aged animals.
Consistent with the expression of stimuli and receptors
that evoke alternative macrophage/microglia activation in
vitro, ICH increased the expression of several markers:
ARG1, MRC1/CD206, CD163, CCL22, CHI3L1,
MMP12. ARG1 is notable because it competes with iNOS
for L-arginine, but while iNOS generates potentially harmful
levels of nitric oxide, ARG1 produces L-ornithine, indirectly
reducing nitric oxide. Further ornithine metabolism produ-
ces L-proline, which is a substrate for collagen synthesis
[54], and has been extensively studied in wound healing
and pulmonary fibrosis. The massive, diffuse accumulation
of collagen in the ICH lesion by day 7 suggests the presence
of ARG1 activity and alternative activation. In aged ani-
mals, increases in ARG1, MRC1, and CD163 were delayed
to between 3 and 7 days. Early induction of iNOS was also
greatly reduced, and it is possible that ARG1 elevation was
not needed to shift L-arginine metabolism away from nitric
oxide production. Although delayed, the increase in MRC1
reached a much higher level on day 7. MRC1 roles in the
brain are not known, but it is important for pinocytosis and
endocytosis by peripheral macrophages [84, 88]; its
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later up-regulated to help remove serum high-mannose glyco-
proteins [89]. Future studies will be needed to address whether
increased MRC1 in aged rats corresponds with, and regulates,
white matter-infiltrating macrophages and microglia.
MMP12 is induced in IL-4 stimulated macrophages [90,
91] and is a recently proposed marker of alternative activa-
tion [92]. MMP12 was the most highly up-regulated of the
genes we analyzed after ICH. In young rats, there were
marked increases in MMP12 expression [21, 27, 93] (pres-
ent study), and at early times (1 and 3 days), it was present
in astrocytes and around fragmented brain microvessels
[21]. Here, we show that in aged rats, the increase was
delayed (7 days), which correlates with the delayed expres-
sion of the alternative activation-related genes, MRC1,
CD163, IL-4Rα, and IL-13Rα. While MMP12 functions
in the brain are not known, there is some evidence for a
deleterious role after ICH. MMP12-deficient mice had less
microglia/macrophage recruitment to the hematoma and
better sensorimotor recovery [93], and minocycline de-
creased MMP12 expression [21, 27], reduced edema and
BBB leakiness [21], and improved the functional outcome
[27]. Future studies will be needed to address whether age-
related changes in MMP12 reflect changes in alternatively
activated macrophages/microglia.
Microglia/macrophage activation is thought to contribute
to the worse injury and poorer outcomes in aged animals
after ICH [10, 73]. There are numerous reports that treat-
ments inhibiting microglia/macrophage activation decrease
hematoma volume and edema formation while improving
neurological outcome [71, 94, 95]. However, the present
study further illustrates the complexity of the innate inflam-
matory response in the first week after experimental ICH in
which the induction of pro-inflammatory, potentially harm-
ful mediators coincides temporally with many resolving and
beneficial molecules. While this first study is necessarily
descriptive, many time- and age-dependent changes were
seen in the expression of inflammation-related genes, with
many being reduced or delayed in aged rats. This evidence
of a shift in the balance of inflammatory processes paves the
way for further studies, including determining when, where,
and in which cell types they are produced and how this
expression changes with aging.
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